Urology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Opelz G et al. – Five–year graft survival in deceased–donor kidney transplant recipients is equivalent in patients receiving CsA– or Tac–based immunosuppression, and in those receiving MPA or AZA. The absence of a survival benefit with modern agents is relevant in the current cost–conscious era of prescribing.

Related Articles

Aerosolized vancomycin for the treatment of MRSA after lung transplantation
Respirology, 11/10/09    Relevance Score: 94%

Pre-transplant lung function is predictive of survival following pediatric bone marrow transplantation
Pediatric Blood & Cancer, 11/05/09    Relevance Score: 94%

Soluble CD30 Levels in Recipients Undergoing Heart Transplantation Do Not Predict Post-transplant Outcome
The Journal of Heart and Lung Transplantation, 10/28/09    Relevance Score: 94%

Factors influencing liver transplant length of stay at two large-volume transplant centers
Liver Transplantation, 11/03/09    Relevance Score: 93%

Fulminant Hepatic Failure due to Varicella Zoster in a Heart Transplant Patient: Successful Liver Transplant
The Journal of Heart and Lung Transplantation, 10/28/09    Relevance Score: 93%

Today in Transplantation...keeping you current

Thymoglobulin Dose Optimization for Induction Therapy in High Risk Kidney Transplant Recipients
Transplantation, 12/07/09

Public Attitudes Toward Kidney Donation By Friends and Altruistic Strangers in the United States
Transplantation, 12/07/09

Arteriovenous fistula in an autotransplanted kidney segment: Successful angiographic management
Scandinavian Journal of Urology and Nephrology, 12/04/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address